HRTX
Heron Therapeuti
NASDAQ: HRTX · HEALTHCARE · BIOTECHNOLOGY
$1.19
-1.65% today
Updated 2026-04-29
Market cap
$224.36M
P/E ratio
—
P/S ratio
1.45x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$1 – $3
Volume
2.1M
Heron Therapeuti (HRTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.39M | $412000.00 | $369000.00 | $1.26M | $1.30M | $646000.00 | $-599000.00 | $0.00 | $0.00 | $0.00 | $1.28M | $30.77M | $77.47M | $145.97M | $88.64M | $86.35M | $107.67M | $127.04M | $144.28M | $154.90M |
| Revenue growth (YoY) | — | -92.4% | -10.4% | +241.7% | +3.2% | -50.3% | -192.7% | +100.0% | — | — | — | +2305.6% | +151.8% | +88.4% | -39.3% | -2.6% | +24.7% | +18.0% | +13.6% | +7.4% |
| Cost of revenue | — | $13.10M | $11.57M | $3.01M | $3.23M | $179000.00 | $8.39M | $13.38M | $54.83M | $61.18M | $35000.00 | $4.59M | $27.51M | $61.62M | $36.19M | $46.02M | $54.87M | $65.11M | $38.65M | $41.35M |
| Gross profit | — | $412000.00 | $369000.00 | $1.26M | $1.30M | $467000.00 | $-599000.00 | $-30.92M | $-54.83M | $-61.18M | $1.24M | $26.18M | $49.96M | $84.35M | $52.45M | $40.33M | $52.80M | $61.94M | $105.64M | $113.56M |
| Gross margin | 0.0% | 100.0% | 100.0% | 100.0% | 100.0% | 72.3% | 100.0% | — | — | — | 97.3% | 85.1% | 64.5% | 57.8% | 59.2% | 46.7% | 49.0% | 48.8% | 73.2% | 73.3% |
| R&D | $15.24M | $19.36M | $19.51M | $7.80M | $7.26M | $8.21M | $15.04M | $32.78M | $54.83M | $61.18M | $103.13M | $138.58M | $140.03M | $167.38M | $174.53M | $130.82M | $107.51M | $39.13M | $16.68M | $12.43M |
| SG&A | $3.63M | $4.68M | $4.31M | $3.71M | $3.97M | $3.50M | $8.79M | $21.68M | $19.73M | $35.74M | $21.37M | $25.55M | $29.26M | $37.90M | $42.23M | $40.15M | $37.44M | $58.48M | $53.40M | $54.60M |
| Operating income | $-18.86M | $-23.63M | $-23.45M | $-10.24M | $-9.93M | $-11.06M | $-23.83M | $-54.46M | $-74.56M | $-96.92M | $-170.91M | $-194.56M | $-183.94M | $-210.69M | $-228.16M | $-217.83M | $-174.66M | $-110.61M | $-11.53M | $-2.54M |
| Operating margin | -349.9% | -5736.2% | -6353.7% | -812.2% | -763.6% | -1712.4% | 3978.5% | — | — | — | -13363.2% | -632.4% | -237.4% | -144.3% | -257.4% | -252.3% | -162.2% | -87.1% | -8.0% | -1.6% |
| EBITDA | $5.91M | $-23.34M | $-23.03M | $-9.89M | $-6.97M | $-10.88M | $-23.63M | $-54.12M | $-73.98M | $-96.19M | $-169.82M | $-192.02M | $-182.42M | $-201.23M | $-225.32M | $-214.81M | $-171.77M | $-103.79M | $-5.06M | $-17.88M |
| EBITDA margin | 109.6% | -5666.0% | -6242.0% | -784.0% | -535.5% | -1684.7% | 3945.6% | — | — | — | -13277.2% | -624.1% | -235.5% | -137.9% | -254.2% | -248.8% | -159.5% | -81.7% | -3.5% | -11.5% |
| EBIT | $5.52M | $-23.70M | $-23.45M | $-10.24M | $-7.19M | $-11.06M | $-23.83M | $-54.46M | $-74.56M | $-96.92M | $-170.91M | $-193.55M | $-183.94M | $-203.28M | $-228.16M | $-217.83M | $-174.66M | $-106.69M | $-7.55M | $-20.20M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $2000.00 | $373000.00 | $599000.00 | $826000.00 | $887000.00 | $958000.00 | $2.66M | $3.94M | $2.67M | $1.47M | $1.90M | $2.41M | $2.47M | $3.87M | $6.03M | $9.61M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $5.27M | $-20.16M | $-23.13M | $-10.03M | $-7.35M | $-11.81M | $-23.35M | $-55.28M | $-76.37M | $-97.59M | $-173.14M | $-197.48M | $-178.84M | $-204.75M | $-224.43M | $-217.66M | $-134.52M | $-110.56M | $-13.58M | $-20.20M |
| Net income growth (YoY) | — | -482.9% | -14.7% | +56.6% | +26.7% | -60.8% | -97.6% | -136.8% | -38.1% | -27.8% | -77.4% | -14.1% | +9.4% | -14.5% | -9.6% | +3.0% | +38.2% | +17.8% | +87.7% | -48.7% |
| Profit margin | 97.7% | -4893.9% | -6266.9% | -795.2% | -564.6% | -1828.8% | 3897.8% | — | — | — | -13537.4% | -641.9% | -230.8% | -140.3% | -253.2% | -252.1% | -124.9% | -87.0% | -9.4% | -13.0% |